MedBeat
Founded in 2018, MedBeat excels in creating advanced cardiac devices, aiming to lower global stroke and sudden cardiac death rates through continuous heart rhythm monitoring. Currently, they’re prioritizing growth, certifications, and market reach, powered by a nine-member team skilled in healthcare and tech.
Key Benefits
- Reduce diagnosis time for patient from 6 months to 2 weeks
- Lower weekly waiting queue from 20 patients to 0
- We can diagnose 9 patients within the space of 18 weeks (average long-term ECG waiting time for 1 patient)